Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors
Abstract only
Saved in:
Published in: | Journal of clinical oncology Vol. 23; no. 16_suppl; p. 3034 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
01-06-2005
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Abstract only |
---|---|
AbstractList | Abstract only |
Author | Evans, T. R. J. George, S. Mastrullo, J. M. Cheng, S. Morgan, J. A. van den Abbeele, A. D. McPherson, I. R. J. Fletcher, J. A. Crawford, D. Demetri, G. D. |
Author_xml | – sequence: 1 givenname: T. R. J. surname: Evans fullname: Evans, T. R. J. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 2 givenname: J. A. surname: Morgan fullname: Morgan, J. A. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 3 givenname: A. D. surname: van den Abbeele fullname: van den Abbeele, A. D. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 4 givenname: I. R. J. surname: McPherson fullname: McPherson, I. R. J. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 5 givenname: S. surname: George fullname: George, S. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 6 givenname: D. surname: Crawford fullname: Crawford, D. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 7 givenname: J. M. surname: Mastrullo fullname: Mastrullo, J. M. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 8 givenname: S. surname: Cheng fullname: Cheng, S. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 9 givenname: J. A. surname: Fletcher fullname: Fletcher, J. A. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT – sequence: 10 givenname: G. D. surname: Demetri fullname: Demetri, G. D. organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT |
BookMark | eNo10M1LwzAYx_EgE9ym_0O86SE1L02THnXoHEwUN8FbSNOUZXZNaVJkR_9zW19OP3jg-R4-MzBpfGMBuCQ4IRTjm73xybA8oSwhmQp929YJwyw9AVPCqUBCcD4BUywYRUSy9zMwC2GPMUkl41Pw9bLTwcIVLH2wyAajax2db2CIfXmEvoJxZ-HmdQF1U8JDX0eHPlwz_rhm5woXfQfvnjaI8VRSPhxhOwRsEwO8amO4hp8u7uBytdn-FPyQ62DwtSth7A--C-fgtNJ1sBd_OwdvD_fbxSNaPy9Xi9s1MgRnKcoZyYnOS20YN6bgTBvMZW4otxRnpZWiMBJzahjBWMpUiLwqssxoQdMy14zNQf7bNZ0PobOVajt30N1REaxGSzVYqtFSUab-LdVoyb4BE69sFA |
CitedBy_id | crossref_primary_10_1517_14728222_10_6_793 crossref_primary_10_1158_1078_0432_CCR_08_0533 crossref_primary_10_1093_annonc_mdm223 crossref_primary_10_1093_annonc_mdn048 crossref_primary_10_1158_1535_7163_MCT_06_0382 crossref_primary_10_1158_1078_0432_CCR_09_2416 crossref_primary_10_1097_CCO_0b013e3281338885 crossref_primary_10_1007_s10637_012_9805_y crossref_primary_10_1007_s11912_008_0053_4 crossref_primary_10_1038_nrclinonc_2009_129 crossref_primary_10_1016_j_ddstr_2005_11_005 crossref_primary_10_1056_NEJMoa055229 crossref_primary_10_1158_1078_0432_CCR_09_0190 crossref_primary_10_1002_pbc_21368 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1200/jco.2005.23.16_suppl.3034 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1527-7755 |
EndPage | 3034 |
ExternalDocumentID | 10_1200_jco_2005_23_16_suppl_3034 |
GroupedDBID | --- .55 .GJ 08G 08P 0R~ 18M 29K 2WC 34G 39C 3O- 4.4 53G 5GY 5RE 5VS 8F7 8WZ A6W AAKAS AAQOH AAQQT AARDX AAWTL AAYEP AAYOK AAYXX ABJNI ABOCM ACGFO ACGFS ACGUR ADBBV ADZCM AEGXH AENEX AFFNX AI. AIAGR ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AWKKM AZFZN BAWUL C45 CITATION CS3 D-I DIK EBS EJD EX3 F5P F9R FBNNL FD8 FEDTE GX1 H13 HVGLF HZ~ IH2 IPNFZ J5H K-O KQ8 L7B LSO MJL N4W N9A NTWIH O9- OK1 OVD OWW P2P QTD R1G RHI RIG RLZ RUC SJN SV3 TEORI TR2 TWZ UDS UHU VH1 VVN WH7 WOQ WOW X7M YCJ YFH YQY ZGI |
ID | FETCH-LOGICAL-c1064-93191a9dac35ccb53ac0589c25e206de87bc8052c3100884779fb66ca724d9a33 |
ISSN | 0732-183X |
IngestDate | Fri Aug 23 01:44:43 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16_suppl |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1064-93191a9dac35ccb53ac0589c25e206de87bc8052c3100884779fb66ca724d9a33 |
PageCount | 1 |
ParticipantIDs | crossref_primary_10_1200_jco_2005_23_16_suppl_3034 |
PublicationCentury | 2000 |
PublicationDate | 2005-06-00 |
PublicationDateYYYYMMDD | 2005-06-01 |
PublicationDate_xml | – month: 06 year: 2005 text: 2005-06-00 |
PublicationDecade | 2000 |
PublicationTitle | Journal of clinical oncology |
PublicationYear | 2005 |
SSID | ssj0014835 |
Score | 1.8181343 |
Snippet | Abstract only |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 3034 |
Title | Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEF-uFYovolXxmxGkKNuN101ySR5Pe9pTKkcvQt9CdrPhTjEpTe-hj_7nzu5mk9gifoAv4W5ghyTzy8zs7HwQ8iIXZThWec5iWQgWhKViSRKWLEDzIsaRFEmsa4ePltGn0_hwFsxGIzeBtKf9V0kjDWWtK2f_QtodUyTgb5Q5XlHqeP0juS9WaJfonBZ1o5hqUARWxI3rHq09zeWJzdk06YTs67rSa9bVai3wAz-nb46XzMdNBg9p33rVhGfPdNZFYqO37-fL1HAxRVwUH2td0IvNt7o9ILru8nZlmHUlfwrnd_586tETj37wOhyYqVMGah6ddmRddIUKk06FUMomRE89etgvk4uV2UoYFTjk6QIcYZ-I1erByOcMNc-pNVmtnuYRbgxsh1-nyG3hsgPsJGv0XNSBckZrHQwMvft7zYhwMx_7i6xtyI37nmPm9SyGjbuvGNQuzVFvsJBFhqz0uM8w437mWGWa1Ra5wVFBmlDA_GN3-hXEdjCse_Ad8ry9r9e_vKuBXzVwkNLb5FYrZphaSN4hI1Xtkp3jNndjl-wtbJf0y31I-6K_Zh_2YNH3T7-8S74bCMMcrkAYDIShLgHxBghhQPDBEMLQQRh6CCMRHIThJQL4FWj4goav4WDgCwa-YOF7j3x-N0vfHrF2UgiTB-hTswQNyUGeFLn0QylF6OdSj8uUPFR8PClUHAmpZ3dIfZwVo0MWJaWYTGQe8aBIct-_T7arulIPCAj0-HG1H0VlHpR-mOTxWJbIPZalkkXxkHD3nrMz2xAm-62cH_3LosfkZv85PCHbF-cb9ZRsNcXmmYHLD1bmrVg |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phase+I+dose-escalation+study+of+the+SRC+and+multi-kinase+inhibitor+BMS-354825+in+patients+%28pts%29+with+GIST+and+other+solid+tumors&rft.jtitle=Journal+of+clinical+oncology&rft.au=Evans%2C+T.+R.+J.&rft.au=Morgan%2C+J.+A.&rft.au=van+den+Abbeele%2C+A.+D.&rft.au=McPherson%2C+I.+R.+J.&rft.date=2005-06-01&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=23&rft.issue=16_suppl&rft.spage=3034&rft.epage=3034&rft_id=info:doi/10.1200%2Fjco.2005.23.16_suppl.3034&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_jco_2005_23_16_suppl_3034 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon |